Effects of low-serum adaptation on growth and protein expression in stably lactoferrin-overexpressing mammary alveolar cells

TL;DR

Researchers adapted mammary cells to grow with low serum while maintaining lactoferrin production, which could reduce costs and improve scalability for industrial applications.

Contribution

A novel low-serum adaptation strategy was developed to sustain bovine mammary cell growth and lactoferrin expression.

Findings

Cells maintained stable proliferation at 1% fetal bovine serum under both adaptation strategies.

Adding knockout serum replacement and insulin-transferrin-selenium increased growth rate by 30%.

Lactoferrin mRNA and protein levels remained consistent under low-serum conditions.

Abstract

Long-term culture with high serum concentrations increases culture costs, accelerates cell senescence, and limits industrial-scale applications. Serum reduction adaptation is an effective solution for addressing these issues. In this study, we aimed to investigate the effects of two low-serum adaptation strategies on the growth and lactoferrin expression in stably LTF-overexpressing bovine mammary alveolar cells transfected with large T antigen (MAC-T).

Two adaptation protocols of serum concentration reduction and dual-medium gradient adaptation were implemented to progressively reduce serum dependence in MAC-T cells.

Under both adaptation modes, cells maintained stable proliferation at 1% fetal bovine serum (FBS). At the 0.5% FBS (serum reduction) and 10% basal control medium, equivalent to 1% FBS in dual-medium adaptation stages, adding 10% knockout™ serum replacement and 1% insulin-transferrin-selenium 5 increased the specific growth rate by 30%, enabling robust cell growth under low-serum conditions.

Across all the low-serum conditions, cells retained typical epithelial morphology (cytokeratin 18-positive) while exhibiting consistent LTF mRNA transcription levels, protein expression, and secretory output. These findings validate the scalable low-serum culturing of MAC-T cells and in vitro LTF synthesis.

Figures